Topical therapy for actinic keratoses, II: Diclofenac, colchicine, and retinoids.

Abstract

Actinic keratoses (AKs) are evolving, malignant cutaneous neoplasms. AKs can be treated with physical or destructive methods and by topical therapies. This article is the second in a 2-part series of current topical therapeutic options for AKs and discusses topical diclofenac, colchicine, and retinoids. The first part focused on topical 5-fluorouracil and imiquimod.

• Authors: William D Tutrone, Ritu Saini, Selin Caglar, Jeffrey M Weinberg, Jorge Crespo
• Journal: Cutis (Cutis) Vol. 71 Issue 5 Pg. 373-9 (May 2003) ISSN: 0011-4162 [Print] United States
• PMID: 12769404 (Publication Type: Journal Article, Review)

Chemical References

• Anti-Inflammatory Agents, Non-Steroidal
• Antineoplastic Agents
• Keratolytic Agents
• Retinoids
• Diclofenac
• Colchicine

Topics

• Administration, Cutaneous
• Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, therapeutic use)
• Antineoplastic Agents (administration & dosage, therapeutic use)
• Colchicine (administration & dosage, therapeutic use)
• Diclofenac (administration & dosage, therapeutic use)
• Humans
• Keratolytic Agents (administration & dosage, therapeutic use)
• Keratosis (drug therapy, pathology)
• Precancerous Conditions (drug therapy, pathology)
• Randomized Controlled Trials as Topic
• Retinoids (administration & dosage, therapeutic use)
• Skin Neoplasms (drug therapy, pathology)